Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. Meet with... New Enterprise Associates

    on the immune-oncology and immunology spaces. He started his career at Johnson and Johnson, where he held multiple ... Business Development roles, at different times, in Global Surgery, Oncology and Emerging Technologies. ...

  2. Publish or Perish: Creating Value through Publications

    Gamble. Dr. Bhattacharyya’s therapeutic experience includes orthopedic, nephrology, oncology ... plans. Dr. Myers therapeutic expertise includes oncology, cardiovascular disease/thrombosis ...

  3. How to Advance in Biotech: Maximize Your Contributions to the Industry Early in your Career

    by BMS), Surface Oncology, and IFM Therapeutics. He serves as a board member of Obsidian Therapeutics ... immuno-oncology investments CoStim Pharmaceuticals (acquired by Novartis) and Unum Therapeutics. Prior to joining ...

  4. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ...

  5. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ...

  6. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ...

  7. The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... CNS and oncology, both in early and late stages of clinical development. His most recent assignment ... and operational aspects, therapeutic area focus on rheumatology, oncology and anti-infectives within ...

  8. Janssen Labs Annual Trends in Financing Holiday Industry Panel

    through clinical trials in oncology. Sutent was the first Sugen product to reach the market in renal cell ... of the company's lead oncology compounds. He was also Vice President of ALZA Pharmaceuticals' Oncology ...

  9. Janssen Labs Annual Trends in Financing Holiday Industry Panel Onsite Registration

    through clinical trials in oncology. Sutent was the first Sugen product to reach the market in renal cell ... of the company's lead oncology compounds. He was also Vice President of ALZA Pharmaceuticals' Oncology ...

  10. Haas Business School of Berkeley Visits JLABS @ SSF

    therapeutic areas including oncology, respiratory, infectious, autoimmune, and gastrointestinal diseases, ...

Pages

Share